Vibrant Wellness introduces the Toxin Genetics Test, a cutting-edge addition to its suite of advanced functional lab tests. This revolutionary tool assesses genetic biomarkers pivotal to the body's detox process, aiding healthcare professionals in designing individualized detoxification plans.

GCAC aims to raise awareness about the impact of genetic testing in diagnosing and treating genetic cardiomyopathy

To meet the significant surge in demand, BillionToOne expands its CLIA laboratory space and its commercial team

From Cultural Curiosity to Health Necessity in COVID

BillionToOne has raised more than $32.5 million. The funding will be used to support the commercial expansion of UNITY™ to all US states

Mako Medical Laboratories announced a new program developed to help families get access to over 300 different medications for free.

Mako Medical CEO Chad Price announced Mako Medical is releasing a new propriety nutritional DNA test focused on optimizing performance.

Mako Medical launches a new genetic test targeted at nutrition and optimized performance.

Germany molecular diagnostics market demand is estimated to witness around a 7.5% CAGR from 2020 to 2026, owing to changing lifestyle preferences, rising incidences of infectious diseases and favorable demographic trends, such as a graying population.

BillionToOne and Eluthia have announced today the launch of the first and only non-invasive prenatal test, allowing to screen for the autosomal-recessive conditions cystic fibrosis, spinal muscular atrophy (SMA), sickle cell disease and other hemoglobinopathies. The UNITY™ screen will be made available through Eluthia in Germany, Austria, Switzerland, and the Netherlands, as of now.

UNITY is the only prenatal screen that tests cell-free fetal DNA for cystic fibrosis, spinal muscular atrophy (SMA) and sickle cell disease using just one tube of blood from the mother.

IDTechEx experts are hosting six half-day forums in Boston at the beginning of June, providing attendees with detailed but concise analysis on some of the latest emerging technology innovations

Part NHS-owned medtech company Rightangled is spearheading a trade mission in the US with partners from the ABHI and Texas Medical School

The Color-Sayre partnership will provide a fully integrated solution for patients and providers by delivering actionable clinical test results at an accessible price point.

The American Society of Breast Surgeons Foundation Examines its 2017 Top 10 Most Read Articles to Identify Patient and Caregiver Education, Information Needs

The American Society of Breast Surgeons Foundation Launches Clues to Solve Breast Issues Contest, Giving 100% of Contest Winnings to Breast Cancer Patients in Need

Baylor Genetics Partners With Rainbow Genomics

9 Healthcare Innovators Will Vie for 3 ABBY Awards; Winners to be Chosen October 26 in Long Beach

Today, Global Research & Data Services is going to publish several market analyses about the In Vitro Diagnostic markets in the world.